Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...